Skip to main content
. Author manuscript; available in PMC: 2008 Oct 6.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Mar 3;49(6):2464–2471. doi: 10.1167/iovs.07-1639

Figure 4.

Figure 4

GGTI-DU40–induced decreases in myosin light-chain phosphorylation in TM cells. To determine the effects of GGTI-DU40 on MLC phosphorylation in TM cells, PTM cells cultured under 0.1% serum for 24 hours were treated with different concentrations of GGTI-DU40 (24 hours). Cell lysates were prepared and evaluated for changes in MLC phosphorylation using immunoblot analysis in conjunction with a phosphospecific anti-MLC polyclonal antibody. (A) Representative immunoblot of MLC phosphorylation in drug-treated samples. (B) Quantitative and significant differences in the MLC phosphorylation between the drug-treated and control samples.